Volume | 142,531 |
|
|||||
Noticias | (2) |
Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
Silexion Therapeutics Corporation | SLXNW | NASDAQ | Warrant Capital Accionario |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
0.044 | 0.036 | 0.055 | 0.0478 | 0.0356 |
Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio |
---|---|---|---|---|
73 | 142,531 | 0.0528686 | 7,535 | - |
Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
---|---|---|---|---|
18:33:23 | formt | 110 | 0.048 | USD |
Información Financiera Silexion Therapeutics Corporation SLXNW
Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
---|---|---|---|---|---|---|
76.95k | - | - | - | 0.16 |
Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
---|---|---|---|---|---|
- | - | - | - |
Noticias sobre Silexion Therapeutics Corporation SLXNW
Fecha | Hora | Fuente | Noticia |
---|---|---|---|
17/1/2025 | 05:56 | Edgar (US Regulatory) | Form 8-K - Current report |
17/1/2025 | 05:44 | Edgar (US Regulatory) | Form 424B4 - Prospectus [Rule 424(b)(4)] |
15/1/2025 | 23:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
15/1/2025 | 15:01 | Edgar (US Regulatory) | Form 8-K - Current report |
15/1/2025 | 05:02 | Edgar (US Regulatory) | Form 8-K - Current report |
14/1/2025 | 16:02 | Edgar (US Regulatory) | Form S-1/A - General form for registration of securities.. |
14/1/2025 | 05:19 | Edgar (US Regulatory) | Form S-1/A - General form for registration of securities.. |
14/1/2025 | 05:01 | Edgar (US Regulatory) | Form 8-K - Current report |
18/12/2024 | 05:00 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of.. |
17/12/2024 | 06:08 | Edgar (US Regulatory) | Form 8-K - Current report |
10/12/2024 | 08:42 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
10/12/2024 | 08:41 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
Histórico SLXNW
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |